H

Hinova Pharmaceuticals Inc
SSE:688302

Watchlist Manager
Hinova Pharmaceuticals Inc
SSE:688302
Watchlist
Price: 54.19 CNY 2.65% Market Closed
Market Cap: 5.4B CNY

Wall Street
Price Targets

Price Targets Summary
Hinova Pharmaceuticals Inc

There are no price targets for Hinova Pharmaceuticals Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Hinova Pharmaceuticals Inc Competitors:
Price Targets
4552
JCR Pharmaceuticals Co Ltd
6% Downside
600535
Tasly Pharmaceutical Group Co Ltd
14% Upside
524731
Jenburkt Pharmaceuticals Ltd
28% Upside
4519
Chugai Pharmaceutical Co Ltd
7% Upside
13
HUTCHMED (China) Ltd
44% Upside
600332
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
8% Upside
LLY
Eli Lilly and Co
4% Upside
AUROPHARMA
Aurobindo Pharma Ltd
15% Upside

Revenue
Forecast

Revenue Estimate
Hinova Pharmaceuticals Inc

For the last 5 years the compound annual growth rate for Hinova Pharmaceuticals Inc's revenue is -39%. The projected CAGR for the next 3 years is 733%.

-39%
Past Growth
733%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Hinova Pharmaceuticals Inc

Operating Income forecast
is not available for
Hinova Pharmaceuticals Inc

Net Income
Forecast

Net Income Estimate
Hinova Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-24%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Hinova Pharmaceuticals Inc's stock price target?
Not Available

Hinova Pharmaceuticals Inc doesn't have any price targets made by Wall Street professionals.

What is Hinova Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
733%

For the last 5 years the compound annual growth rate for Hinova Pharmaceuticals Inc's revenue is -39%. The projected CAGR for the next 3 years is 733%.

Back to Top